TY - JOUR
T1 - Binary Copolymer Blending Enhances pDNA Delivery Performance and Colloidal Shelf Stability of Quinine-Based Polyplexes
AU - Roy, Punarbasu
AU - Kreofsky, Nicholas W.
AU - Santa Chalarca, Cristiam F
AU - Reineke, Theresa M.
N1 - Publisher Copyright:
© 2025 American Chemical Society.
PY - 2025
Y1 - 2025
N2 - Successful gene therapies require the efficient delivery of the therapeutic nucleic acids in the target cells, which is a major bottleneck. Our group has demonstrated that quinine-based polymers are effective and promising carriers for delivering nucleic acids, such as plasmid DNA (pDNA). However, the inherent hydrophobicity of quinine-based polymers makes the polymer-pDNA complexes (polyplexes) colloidally unstable leading to aggregation, which is relevant in clinical scenarios as larger particles (diameter >1000 nm) tend to perform poorly when administered systemically in vivo. Herein, we overcome the hydrophobicity-induced aggregation by using two types of quinine-based polymer systems to form polyplexes via a facile blending approach. We balanced desirable properties using quinine-based copolymers (HQ-X) as the pDNA binding component along with a quinine-based diblock copolymer (PHQ), having a polyethylene glycol chain, to provide colloidal stability to the particles. Using 5 polymer pairs, 5 mixing ratios, and 3 mixing sequences, we screened 66 formulations out of which 37 resulted in nonaggregating small polyplexes (diameter <300 nm) with colloidal stability tested up to 7 days at 4 °C. Furthermore, 18 out of these 37 colloidally stable formulations showed transfection performance better than or comparable to the commercial control, jetPEI. Our results clearly indicated that while the three mixing sequences generate polyplexes of similar characteristics, the best balance of transfection efficiency, toxicity, and colloidal stability is achieved at moderate PHQ % in the mixture when colloidal stability does not compromise payload binding. Our results showcase that polymer blending, in a manner similar to lipids, is an effective and parallel approach to achieving desirable polyplex characteristics, such as particle size, colloidal stability, and performance.
AB - Successful gene therapies require the efficient delivery of the therapeutic nucleic acids in the target cells, which is a major bottleneck. Our group has demonstrated that quinine-based polymers are effective and promising carriers for delivering nucleic acids, such as plasmid DNA (pDNA). However, the inherent hydrophobicity of quinine-based polymers makes the polymer-pDNA complexes (polyplexes) colloidally unstable leading to aggregation, which is relevant in clinical scenarios as larger particles (diameter >1000 nm) tend to perform poorly when administered systemically in vivo. Herein, we overcome the hydrophobicity-induced aggregation by using two types of quinine-based polymer systems to form polyplexes via a facile blending approach. We balanced desirable properties using quinine-based copolymers (HQ-X) as the pDNA binding component along with a quinine-based diblock copolymer (PHQ), having a polyethylene glycol chain, to provide colloidal stability to the particles. Using 5 polymer pairs, 5 mixing ratios, and 3 mixing sequences, we screened 66 formulations out of which 37 resulted in nonaggregating small polyplexes (diameter <300 nm) with colloidal stability tested up to 7 days at 4 °C. Furthermore, 18 out of these 37 colloidally stable formulations showed transfection performance better than or comparable to the commercial control, jetPEI. Our results clearly indicated that while the three mixing sequences generate polyplexes of similar characteristics, the best balance of transfection efficiency, toxicity, and colloidal stability is achieved at moderate PHQ % in the mixture when colloidal stability does not compromise payload binding. Our results showcase that polymer blending, in a manner similar to lipids, is an effective and parallel approach to achieving desirable polyplex characteristics, such as particle size, colloidal stability, and performance.
UR - http://www.scopus.com/inward/record.url?scp=86000636238&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=86000636238&partnerID=8YFLogxK
U2 - 10.1021/acs.bioconjchem.5c00040
DO - 10.1021/acs.bioconjchem.5c00040
M3 - Article
C2 - 40067683
AN - SCOPUS:86000636238
SN - 1043-1802
JO - Bioconjugate Chemistry
JF - Bioconjugate Chemistry
ER -